Sanofi Ventures

Investor type

CVC

Founded

2004

AUM

-

Location

Cambridge, Massachusetts, United States

Investment Ticket

$10-50 m

Investment Stage

Series A Seed Series B

Region of investment

North America Europe
Investor profile last updated: 30 August, 2026

Profile

Sanofi Ventures is a strategic venture fund based in France, launched by the pharmaceutical giant Sanofi. They are an early-stage investor focusing on transformational science and technology in the biotech and digital health sectors. The team is composed of experienced professionals such as Jason P. Hafler (Managing Director), Laia Crespo (Partner), and Cris De Luca (Partner) among others. The firm separates itself by providing strategic insights and long-term support to its portfolio companies, drawing from its deep industry knowledge as part of Sanofi.

Sanofi Ventures invests in top-tier biotech and digital health firms that aim to enhance patient care and transform medical practices. They participate across various stages, including Seed to Series B, frequently leading financings and holding board positions. Although specific check sizes aren't disclosed, their strategic partnership with Sanofi suggests significant resources could be deployed. They seek opportunities worldwide but with a strategic alignment to Sanofi’s corporate goals.

Notable portfolio companies include Memento Medicines (biotherapeutic development), Bionyra (health innovation), BranchLab (biotech tools), QuantHealth (AI-powered digital twins), Fulcrum Therapeutics (muscular dystrophy therapy), and i2O Therapeutics (nanobody medicine delivery). These investments reflect their focus on cutting-edge solutions in biotechnology and digital health sectors.

Industry

Pharmaceuticals Medical Devices Marketing and Advertising Healthcare Services Digital Biotechnology AI Life Sciences HealthTech

Contacts

Name
Title
Email
avatar
Christopher Gagliardi Director of Investments
Director of Investments
-
avatar
Jason P. Hafler Managing Director
Managing Director
-
Upgrade to see contacts
avatar
Ruj1Fc0m3z84bgvB Ruj1Fc0m3z84bgvB
Ruj1Fc0m3z84bgvB
avatar
Ruj1Fc0m3z84bgvB Ruj1Fc0m3z84bgvB
Ruj1Fc0m3z84bgvB
avatar
Ruj1Fc0m3z84bgvB Ruj1Fc0m3z84bgvB
Ruj1Fc0m3z84bgvB
Investment-team contacts for Sanofi Ventures — including verified work emails and LinkedIn profiles — are available to Private Equity List subscribers.
Instant access on the web. Plans from $129/month — see pricing.
Contacts sourced from the firm's website and LinkedIn, re-verified on a rolling cycle. Spot a stale contact, or none at all? Report it — we re-run that firm within 48h and get back to you.

FAQs about Sanofi Ventures

Sanofi Ventures operates as a corporate VC (CVC). It backs companies at Series A, Seed and Series B, writing tickets of $10-50 m.
Sanofi Ventures is located in Cambridge, Massachusetts, United States.
Sanofi Ventures was founded in 2004.
Sanofi Ventures invests in companies and startups in Pharmaceuticals, Medical Devices, Marketing and Advertising, Healthcare Services, Digital, Biotechnology, AI, Life Sciences, HealthTech.
Sanofi Ventures invests in companies and startups in North America, Europe.
Sanofi Ventures invests in companies and startups at Series A, Seed, Series B.
Sanofi Ventures usually invests $10-50 m on average.
Sanofi Ventures can be reached through its website sanofiventures.com, its LinkedIn page and its X account. Cold-mailing a general inbox rarely reaches a partner, so Private Equity List also lists the investment-team contacts for Sanofi Ventures — names, roles, verified work emails and LinkedIn profiles — available on a Pro plan from $129/month (see pricing). Contacts are sourced from the firm's website and LinkedIn and re-verified on a rolling cycle. Spot a stale contact, or none at all? Report it — we re-run that firm within 48h and get back to you.
Yes. Every field on this page — profile, funds, investment criteria, portfolio and investment-team contacts — is available programmatically through the Private Equity List REST API and MCP server, so AI assistants such as Claude and ChatGPT can query Sanofi Ventures directly instead of scraping this page. One subscription covers both the web app and machine access — see API & MCP.
Private Equity List re-verifies investor profiles on a rolling cycle, pulling from the firm's own website and LinkedIn rather than a one-off import. This profile was last updated on 30 August, 2026. Something out of date here? Report it — we re-run that firm within 48h and get back to you.